It's had its run Stoney. It's a multi-nat dinosaur based out of friggin' Chicago. FX is gonna kill their next earnings report. They sell street-sweepers and septic pump trucks... it doesn't get any lower PE than that stuff. Lousy dividend too.
FROM NOW ON THIS IS THE SECRETE SIGNAL ONLY ONE MAN WAS CORRECT<---- ONLY ONE MAN CALLED THE BOTTOM <------------ WHEN ALL OTHERS WERE SCARED AND 1 IN PARTICULAR PEED HIS PANTS ON NATIONAL TV ONE MAN STEPPED UP.... AND ATE A GUMMY. FIXED THE FED & STOPPED THE MADNESS,,, WHEN WILL JIMMY GET ON BOARD THE RALLY? WHEN WILL OVERNIGHT ADMIT HIS FOLLY?
They own 40 different companies. Typical old-school, pre-1999 MBA mindset. The only hope would perhaps be a sum-of-the parts play.
Word To The Children-) We are up $10 on Disney I may sell later today <------- Someone do a chart read!
... also what i like about FSS is after the buy... Federal Signal Announces New $800 Million Credit Facility Mon, October 24, 2022, 8:00 AM In this article: FSS +3.64% OAK BROOK, Ill.,Oct. 24, 2022/PRNewswire/ -- Federal Signal Corporation (NYSE: FSS) (the "Company"), a leader in environmental and safety solutions, announced the completion of a new five-year$800 millioncredit facility, to replace its existing$500 millioncredit facility. The new facility is comprised of a$675 millionrevolving credit facility and a$125 millionterm loan facility. The arrangement also provides the Company with the ability to further expand its borrowing capacity by up to the greater of (i)$400 millionand (ii) 100% of Consolidated EBITDA for the applicable four-quarter period preceding such expansion notice, subject to approval by applicable lenders. Jennifer L. Sherman, Federal Signal's President and Chief Executive Officer, commented, "We are extremely pleased to announce this new credit facility, which provides greater financial flexibility to invest in internal growth initiatives and pursue additional acquisitions. The terms of the new facility are more favorable to the Company, reflecting our strong cash flow and balance sheet. This marks another important milestone for the Company, as we continue to execute on our strategic long-term growth objectives." The syndication of the new facility was completed with Wells Fargo Securities, LLC, PNC Capital Markets LLC and Truist Securities, Inc. acting as Joint Lead Arrangers and Joint Bookrunners, PNC Bank, National Association and Truist Bank as Syndication Agents, and JPMorgan Chase Bank, N.A. and The Toronto Dominion Bank,New YorkBranch as Documentation Agents.
Futures are slightly Up I am out of here! One thing i don't like about STOKE is it's about the eyes and for whatever reason the eyse have been a tricky place for me in Biotech. I had one huge score with Alergan but over the years many of these eye based bios have crapped out. Much rather be in cancer game<-- As well I am having REAL serious issues with my own eyes don't tell my wife... I'm not exactly a go to the Dr guy but... Something has to give here so reading about various fatal eye conditions does not warm my heart. TALK TO YOU AT 2:00 pm. ~si Stoke Therapeutics Enrolls First Patient in a Natural History Study of People Living with Autosomal Dominant Optic Atrophy (ADOA) August 25, 2022 In this article: STOK +4.04% – ADOA is primarily caused by mutations in the OPA1 gene that result in progressive and irreversible vision loss in both eyes starting in the first decade of life – – The FALCON study is designed to evaluate disease progression and its effects on patients – – Data will support clinical development plans for STK-002, a potential new medicine that targets the underlying cause of ADOA –